Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction

Published:2021-10 Issue: Volume:335 Page:135-141
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Sato Ryosuke,Okada Kozo,Akiyama Eiichi,Konishi Masaaki,Matsuzawa Yasushi,Nakahashi Hidefumi^ORCID,Minamimoto Yugo,Kimura Yuichiro,Maejima Nobuhiko,Iwahashi Noriaki,Hibi Kiyoshi,Kosuge Masami,Ebina Toshiaki^ORCID,Tamura Kouichi^ORCID,Kimura Kazuo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Decreased appendicular skeletal muscle mass is associated with poor outcomes after ST-segment elevation myocardial infarction;Sato;J. Atherosclerosis Thromb.,2020

2. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement;Neeland;The lancet Diabetes & endocrinology,2019

3. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study;Fukuda;Cardiovasc. Diabetol.,2018

4. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes;Fukuda;J Diabetes Investig,2018

5. Clinical impact of visceral-to-subcutaneous fat ratio in patients with acute aortic dissection;Miura;PloS One,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management;Nutrients;2024-08-20

2. Targeting obesity for therapeutic intervention in heart failure patients;Expert Review of Cardiovascular Therapy;2024-06-02

3. Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome;Current Obesity Reports;2024-05-16

4. Musculoskeletal disorders and coronary artery disease —promising molecular markers: literature review;CardioSomatics;2024-04-10

5. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management;Frontiers in Endocrinology;2023-06-30